Nifty
:
24430.35
Sensex
:
78285.07
159.50 (0.66%)
521.16 (0.67%)
Nifty
Sensex
:
:
24430.35
78285.07
159.50 (0.66%)
521.16 (0.67%)

Gennex Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
55/99

BSE: 531739 | NSE: Not Listed

NSE BSE
10.24
06-Jul-2026
  • Open
  • High
  • Low
  • Previous Close
  •  10.05
  •  10.48
  •  10.05
  •  10.16
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  215120
  •  2203143
  •  10.48
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 248.78
  • 11.86
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 232.31
  • N/A
  • 1.12

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 23.63%
  • 15.07%
  • 55.78%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.52%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.39
  • 18.25
  • 28.10

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.42
  • 20.64
  • 28.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.62
  • 35.01
  • 54.43

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.24
  • 24.98
  • 23.29

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.82
  • 2.06
  • 2.03

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.78
  • 17.57
  • 18.52

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
60.95
40.33
51.13%
42.96
40.01
7.37%
39.30
33.38
17.74%
34.18
28.32
20.69%
Expenses
55.07
38.31
43.75%
34.38
32.85
4.66%
31.75
25.93
22.45%
29.11
24.09
20.84%
EBITDA
5.89
2.01
193.03%
8.57
7.15
19.86%
7.55
7.45
1.34%
5.07
4.23
19.86%
EBIDTM
9.66%
4.99%
19.96%
17.88%
19.22%
22.33%
14.84%
14.93%
Other Income
1.32
3.83
-65.54%
0.00
0.00
0
0.00
0.00
0
2.28
2.46
-7.32%
Interest
1.08
1.20
-10.00%
1.11
0.84
32.14%
1.03
1.11
-7.21%
0.98
0.73
34.25%
Depreciation
1.16
0.54
114.81%
0.52
0.50
4.00%
0.47
0.22
113.64%
0.50
0.45
11.11%
PBT
4.67
3.95
18.23%
6.64
5.81
14.29%
6.06
6.12
-0.98%
5.87
5.51
6.53%
Tax
0.21
0.89
-76.40%
0.65
0.75
-13.33%
0.55
0.75
-26.67%
0.85
0.85
0.00%
PAT
4.46
3.07
45.28%
5.99
5.06
18.38%
5.51
5.37
2.61%
5.02
4.66
7.73%
PATM
7.32%
7.61%
13.95%
12.66%
14.02%
16.09%
14.68%
16.45%
EPS
0.18
0.14
28.57%
0.22
0.20
10.00%
0.21
0.21
0.00%
0.22
0.20
10.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
177.39
137.90
86.71
65.60
61.21
59.65
55.62
55.80
43.78
41.91
Net Sales Growth
24.89%
59.04%
32.18%
7.17%
2.62%
7.25%
-0.32%
27.46%
4.46%
 
Cost Of Goods Sold
128.52
97.08
48.85
39.91
38.10
35.72
33.62
32.70
26.73
23.93
Gross Profit
48.87
40.82
37.86
25.69
23.11
23.93
22.00
23.11
17.05
17.98
GP Margin
27.55%
29.60%
43.66%
39.16%
37.76%
40.12%
39.55%
41.42%
38.94%
42.90%
Total Expenditure
150.31
121.21
69.68
60.91
55.84
53.12
52.37
51.78
41.59
37.38
Power & Fuel Cost
-
4.71
4.67
4.39
3.17
3.01
3.30
2.85
2.26
1.97
% Of Sales
-
3.42%
5.39%
6.69%
5.18%
5.05%
5.93%
5.11%
5.16%
4.70%
Employee Cost
-
8.35
7.79
7.87
6.97
7.21
6.81
6.12
5.55
4.96
% Of Sales
-
6.06%
8.98%
12.00%
11.39%
12.09%
12.24%
10.97%
12.68%
11.83%
Manufacturing Exp.
-
3.31
2.81
3.80
3.19
3.15
4.82
5.24
3.50
2.84
% Of Sales
-
2.40%
3.24%
5.79%
5.21%
5.28%
8.67%
9.39%
7.99%
6.78%
General & Admin Exp.
-
4.41
2.99
1.78
1.21
1.02
1.57
1.91
1.50
1.85
% Of Sales
-
3.20%
3.45%
2.71%
1.98%
1.71%
2.82%
3.42%
3.43%
4.41%
Selling & Distn. Exp.
-
2.43
1.61
2.53
2.13
2.40
1.69
2.26
1.49
1.23
% Of Sales
-
1.76%
1.86%
3.86%
3.48%
4.02%
3.04%
4.05%
3.40%
2.93%
Miscellaneous Exp.
-
0.92
0.96
0.62
1.06
0.61
0.56
0.69
0.57
0.60
% Of Sales
-
0.67%
1.11%
0.95%
1.73%
1.02%
1.01%
1.24%
1.30%
1.43%
EBITDA
27.08
16.69
17.03
4.69
5.37
6.53
3.25
4.02
2.19
4.53
EBITDA Margin
15.27%
12.10%
19.64%
7.15%
8.77%
10.95%
5.84%
7.20%
5.00%
10.81%
Other Income
3.60
10.45
4.91
3.95
1.38
0.52
0.95
0.78
0.90
0.12
Interest
4.20
3.61
3.08
1.35
0.88
0.74
0.75
0.79
0.73
0.71
Depreciation
2.65
1.99
2.37
0.92
0.79
0.88
1.00
0.98
0.92
0.84
PBT
23.24
21.55
16.49
6.37
5.09
5.43
2.44
3.03
1.44
3.10
Tax
2.26
3.27
3.32
1.45
1.17
1.02
0.69
0.81
0.62
0.40
Tax Rate
9.72%
15.28%
20.13%
22.76%
22.99%
20.16%
27.06%
26.73%
42.76%
12.90%
PAT
20.98
18.12
13.18
4.92
3.92
4.04
1.86
2.22
0.84
2.70
PAT before Minority Interest
19.74
18.12
13.18
4.92
3.92
4.04
1.86
2.22
0.84
2.70
Minority Interest
-1.24
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.83%
13.14%
15.20%
7.50%
6.40%
6.77%
3.34%
3.98%
1.92%
6.44%
PAT Growth
15.53%
37.48%
167.89%
25.51%
-2.97%
117.20%
-16.22%
164.29%
-68.89%
 
EPS
0.86
0.75
0.54
0.20
0.16
0.17
0.08
0.09
0.03
0.11

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
186.69
170.38
80.35
43.82
39.71
35.67
33.82
31.77
30.94
Share Capital
22.74
22.74
18.02
12.65
12.65
12.65
12.65
12.65
12.65
Total Reserves
158.22
141.92
62.33
31.16
27.06
23.02
21.16
19.12
18.29
Non-Current Liabilities
16.72
12.99
16.15
0.00
0.17
0.41
0.62
1.04
1.13
Secured Loans
14.06
13.22
16.29
0.00
0.00
0.00
0.00
0.35
0.09
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.08
0.10
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
44.56
40.30
29.51
24.21
19.02
20.86
17.30
17.66
17.14
Trade Payables
13.16
15.18
7.08
7.74
5.94
8.13
8.15
12.16
9.46
Other Current Liabilities
12.82
13.69
17.39
3.63
3.29
5.33
3.15
2.92
3.43
Short Term Borrowings
10.22
5.72
1.05
10.12
7.36
4.98
4.54
2.12
3.75
Short Term Provisions
8.36
5.71
3.99
2.71
2.43
2.42
1.46
0.45
0.50
Total Liabilities
255.87
229.75
132.18
68.03
58.90
56.94
51.74
50.47
49.21
Net Block
59.55
55.64
73.73
13.70
14.13
14.93
15.64
15.58
15.51
Gross Block
82.05
76.23
92.23
30.61
30.34
30.26
29.97
28.93
27.99
Accumulated Depreciation
22.50
20.59
18.50
16.92
16.22
15.33
14.33
13.35
12.49
Non Current Assets
74.73
67.94
83.50
20.84
22.52
21.98
22.69
22.80
22.97
Capital Work in Progress
5.22
2.32
0.02
0.00
0.00
0.00
0.00
0.00
0.23
Non Current Investment
0.01
0.01
0.01
6.83
6.83
6.83
6.83
7.00
7.01
Long Term Loans & Adv.
0.87
0.88
0.65
0.32
1.57
0.22
0.22
0.22
0.22
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
181.13
161.81
48.68
47.18
36.38
34.97
29.04
27.66
26.24
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
35.94
25.17
15.69
7.74
5.02
7.44
5.33
2.34
2.89
Sundry Debtors
14.16
17.81
9.42
11.31
7.66
6.28
10.40
10.46
10.30
Cash & Bank
55.57
60.97
15.06
8.31
1.07
0.91
3.15
1.02
0.63
Other Current Assets
75.46
1.34
1.00
0.60
22.63
20.34
10.18
13.84
12.42
Short Term Loans & Adv.
73.92
56.51
7.50
19.22
21.47
18.28
7.68
10.73
11.28
Net Current Assets
136.57
121.51
19.17
22.97
17.36
14.11
11.74
10.00
9.10
Total Assets
255.86
229.75
132.18
68.02
58.90
56.95
51.73
50.46
49.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
-10.80
-46.69
23.68
11.91
-1.44
-1.67
1.88
3.16
-0.11
PBT
21.40
16.49
6.37
5.28
5.06
2.55
3.03
1.45
3.10
Adjustment
-3.97
1.65
-0.39
2.57
1.57
1.68
1.73
1.56
1.52
Changes in Working Capital
-25.00
-64.83
17.69
5.18
-6.54
-5.90
-2.53
1.16
-4.03
Cash after chg. in Working capital
-7.58
-46.69
23.68
13.02
0.10
-1.67
2.23
4.17
0.59
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.22
0.00
0.00
-1.11
-1.53
0.00
-0.35
-1.01
-0.70
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
0.82
18.91
-38.33
-2.47
-0.02
-0.22
-0.99
-0.67
-0.97
Net Fixed Assets
-5.76
-2.84
-2.01
-0.27
-0.08
-0.29
-1.04
-0.71
Net Investments
0.00
0.00
-1.25
0.00
0.00
0.00
0.00
0.00
Others
6.58
21.75
-35.07
-2.20
0.06
0.07
0.05
0.04
Cash from Financing Activity
4.57
73.68
21.03
-1.83
1.62
-0.35
1.25
-2.10
0.86
Net Cash Inflow / Outflow
-5.41
45.91
6.38
7.61
0.16
-2.23
2.13
0.39
-0.22
Opening Cash & Equivalents
60.98
15.06
8.68
1.07
0.91
3.15
1.02
0.63
0.85
Closing Cash & Equivalent
55.57
60.98
15.06
8.68
1.07
0.91
3.15
1.02
0.63

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
7.96
7.24
4.53
3.30
2.99
2.82
2.67
2.51
2.45
ROA
7.46%
7.28%
4.92%
6.18%
6.97%
3.42%
4.35%
1.68%
5.50%
ROE
10.49%
10.77%
7.95%
9.39%
10.71%
5.34%
6.77%
2.67%
8.74%
ROCE
12.49%
13.64%
10.19%
11.82%
13.24%
8.36%
10.52%
6.31%
10.91%
Fixed Asset Turnover
1.97
1.17
1.17
2.14
2.10
1.99
2.04
1.66
1.55
Receivable days
37.35
50.53
52.65
53.05
39.96
50.76
63.48
80.13
86.42
Inventory Days
71.39
75.85
59.51
35.67
35.71
38.85
23.33
20.19
24.26
Payable days
53.27
83.15
67.75
65.55
71.92
88.41
71.54
98.37
99.73
Cash Conversion Cycle
55.46
43.23
44.40
23.17
3.75
1.21
15.27
1.94
10.95
Total Debt/Equity
0.13
0.12
0.22
0.23
0.19
0.14
0.13
0.08
0.13
Interest Cover
6.93
6.36
5.71
6.80
7.81
4.38
4.81
2.99
5.40

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.